Monday, September 24, 2018

Amarin Surges on Fish-Oil Drug Data

Amarin more than tripled in value after the company said its drug derived from fish oil reduced the risk of heart attacks, strokes and deaths in certain high-risk patients.

from WSJ.com: US Business https://ift.tt/2IbrKgX
via IFTTT

No comments:

Post a Comment